KINGWORLD (01110) announced that it expects to return to profitability in the second half of 2025, with the company's attributable net profit turning positive from a loss of approximately RMB 5.4 million in the first half. However, the group still anticipates that the full-year attributable net profit for 2025 will decrease by about 70% to 75% compared to the RMB 41.6 million recorded in 2024. The board attributes the expected decline in net profit primarily to the following factors: (i) a reduction of approximately 15% to 20% in the gross profit margin of its Chinese distribution business for branded imported pharmaceutical and healthcare products, mainly due to a slowdown in market demand for related products; and (ii) a projected decrease of about 40% to 45% in promotion service fee income for the current year, compared to the previous year's RMB 12.6 million, largely resulting from a reduction in the number of promotion projects.